Plain language summary: comparing ivonescimab with pembrolizumab in people with PD-L1-positive non-small cell lung cancer in the HARMONi-2 study.

Saved in:
Bibliographic Details
Title: Plain language summary: comparing ivonescimab with pembrolizumab in people with PD-L1-positive non-small cell lung cancer in the HARMONi-2 study.
Authors: Wang L; aShanghai Pulmonary Hospital, Tongji University of School of Medicine, Shanghai, China., Yao W; bSichuan Cancer Hospital, Chengdu, China., Shen H; cThe Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Xie C; dZhongnan Hospital of Wuhan University, Wuhan, China., Chen H; eAffiliated Hospital of Guangdong Medical University, Zhanjiang, China., Chen K; fThe First Affiliated Hospital of Soochow University, Suzhou, China., Su W; gShanxi Cancer Hospital, Taiyuan, China., Gan X; hThe First Affiliated Hospital of Nanchang University, Nanchang, China., Zhuo M; iBeijing Cancer Hospital, Beijing, China., Chen E; jShaw Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou, China., Xu Z; kThe Second Affiliated Hospital of PLA Army Medical University, Chongqing, China., Zhang Y; lShijiazhuang People's Hospital (Jianhua Hospital), Shijiazhuang, China., Wang M; mPeking Union Medical College Hospital, Beijing, China., Ma R; nLiaoning Cancer Hospital, Shenyang, China., Wu H; oNingbo Medical Center Li Huili Hospital, Ningbo, China., Zhang Z; pAnhui Provincial Cancer Hospital, Hefei, China., Ye F; qThe First Affiliated Hospital of Xiamen University, Xiamen, China., Moore AC; rSummit Therapeutics, Menlo Park, CA, USA., Zhou C; aShanghai Pulmonary Hospital, Tongji University of School of Medicine, Shanghai, China.; sShanghai East Hospital, Shanghai, China.
Source: Future oncology (London, England) [Future Oncol] 2026 Jan; Vol. 22 (1), pp. 27-36. Date of Electronic Publication: 2025 Dec 28.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1744-8301
DOI:10.1080/14796694.2025.2601138